Molecular Periphery Design Allows Control of the New Nitrofurans Antimicrobial Selectivity.

ESKAPE M. tuberculosis antibacterial selectivity azoreductase flexible docking nitrofurans nitroreductase strained ligand–protein interactions

Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
17 Jul 2024
Historique:
received: 24 05 2024
revised: 12 07 2024
accepted: 13 07 2024
medline: 27 7 2024
pubmed: 27 7 2024
entrez: 27 7 2024
Statut: epublish

Résumé

A series of 13 new 3-substituted 5-(5-nitro-2-furyl)-1,2,4-oxadiazoles was synthesized from different aminonitriles. All compounds were screened in the disc diffusion test at a 100 μg/mL concentration to determine the bacterial growth inhibition zone presence and diameter, and then the minimum inhibitory concentrations (MICs) were determined for the most active compounds by serial dilution. The compounds showed antibacterial activity against ESKAPE bacteria, predominantly suppressing the growth of 5 species out of the panel. Some compounds had similar or lower MICs against ESKAPE pathogens compared to ciprofloxacin, nitrofurantoin, and furazidin. In particular, 3-azetidin-3-yl-5-(5-nitro-2-furyl)-1,2,4-oxadiazole (

Identifiants

pubmed: 39064943
pii: molecules29143364
doi: 10.3390/molecules29143364
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Ministry of Science and Higher Education of the Russian Federation
ID : 075-15-2021-689

Auteurs

Lyubov Vinogradova (L)

Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.

Alexey Lukin (A)

Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.

Kristina Komarova (K)

Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.

Maxim Zhuravlev (M)

Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.

Artem Fadeev (A)

Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.

Mikhail Chudinov (M)

Lomonosov Institute of Fine Chemical Technologies, MIREA-Russian Technological University, 119454 Moscow, Russia.

Elizaveta Rogacheva (E)

Pasteur Institute of Epidemiology and Microbiology, 197101 Saint Petersburg, Russia.

Lyudmila Kraeva (L)

Pasteur Institute of Epidemiology and Microbiology, 197101 Saint Petersburg, Russia.

Maxim Gureev (M)

Institute of Cytology, Russian Academy of Sciences, Tikhoretsky Ave. 4, 194064 Saint Petersburg, Russia.

Yuri Porozov (Y)

Laboratory of Angiopathology, The Institute of General Pathology and Pathophysiology, 8 Baltiyskaya Street, 125315 Moscow, Russia.
Advitam Laboratory, Mihaila Shushkaloviћа 13, 11030 Belgrade, Serbia.

Marine Dogonadze (M)

Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, 191036 Saint Petersburg, Russia.

Tatiana Vinogradova (T)

Saint-Petersburg State Research Institute of Phthisiopulmonology of the Ministry of Healthcare of the Russian Federation, 191036 Saint Petersburg, Russia.

Classifications MeSH